Literature DB >> 24114680

Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study.

Reese W Randle1, Shuja Ahmed, Naeem A Newman, Clancy J Clark.   

Abstract

BACKGROUND: Previous case series report that neuroendocrine tumors (NETs) of the ampulla of Vater have worse overall survival (OS) than NETs in the duodenum. We aimed to compare the OS of patients with ampullary NETs to patients with duodenal NETs.
METHODS: This retrospective comparative cohort study used the Surveillance, Epidemiology, and End Results (SEER) registry from 1988 to 2009. OS was evaluated using Kaplan-Meier estimates and Cox proportional hazard regression.
RESULTS: Ampullary NETs (n = 120) were larger (median size 18 vs. 10 mm, p < 0.001), higher grade (poorly and undifferentiated tumor 42 % vs. 12 %, p < 0.001), higher SEER historic stage (distant metastasis 16 % vs. 7 %, p < 0.001), and more often resected (78 % vs. 60 %, p < 0.001) than duodenal NETs (n = 1,360). Median OS was significantly worse for patients with ampullary NETs than with duodenal NETs (98 vs. 143 months, p = 0.037). Local resection was performed for 50.5 % of the resected ampullary NETs and resulted in similar OS compared to locally resected duodenal NETs (HR 1.37, 95 % CI 0.76-2.48, p = 0.291).
CONCLUSIONS: While ampullary NETs are more advanced at presentation and have worse OS than duodenal NETs, long-term survival is possible with proximal small bowel NETs. For locally resected NETs, OS is similar between ampullary and duodenal NETs.

Entities:  

Mesh:

Year:  2013        PMID: 24114680     DOI: 10.1007/s11605-013-2365-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  22 in total

1.  Limitations of claims and registry data in surgical oncology research.

Authors:  Hari Nathan; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2007-11-07       Impact factor: 5.344

2.  Carcinoid tumors of the duodenum and ampulla of vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison.

Authors:  L Bornstein-Quevedo; A Gamboa-Domínguez
Journal:  Hum Pathol       Date:  2001-11       Impact factor: 3.466

3.  Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors.

Authors:  H R Makhlouf; A P Burke; L H Sobin
Journal:  Cancer       Date:  1999-03-15       Impact factor: 6.860

Review 4.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 5.  Ampullary carcinoid tumors: rationale for an aggressive surgical approach.

Authors:  Wilson M Clements; Stephen P Martin; Grant Stemmerman; Andrew M Lowy
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

Review 6.  Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features.

Authors:  E Hatzitheoklitos; M W Büchler; H Friess; B Poch; M Ebert; W Mohr; T Imaizumi; H G Beger
Journal:  Cancer       Date:  1994-03-15       Impact factor: 6.860

Review 7.  Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging.

Authors:  David S Klimstra
Journal:  Semin Oncol       Date:  2013-02       Impact factor: 4.929

8.  Neuroendocrine tumors of the ampulla of Vater: biological behavior and surgical management.

Authors:  Jonathan T Carter; James P Grenert; Laura Rubenstein; Lygia Stewart; Lawrence W Way
Journal:  Arch Surg       Date:  2009-06

9.  Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis.

Authors:  Traian Dumitrascu; Simona Dima; Vlad Herlea; Victor Tomulescu; Mihnea Ionescu; Irinel Popescu
Journal:  Langenbecks Arch Surg       Date:  2012-04-03       Impact factor: 3.445

10.  A carcinoid tumor of the ampulla of Vater treated by endoscopic snare papillectomy.

Authors:  Dae-Keun Pyun; Gyoo Moon; Jimin Han; Myung-Hwan Kim; Sang Soo Lee; Dong-Wan Seo; Sung-Koo Lee
Journal:  Korean J Intern Med       Date:  2004-12       Impact factor: 2.884

View more
  28 in total

1.  GIPR expression in gastric and duodenal neuroendocrine tumors.

Authors:  Scott K Sherman; Jessica E Maxwell; Jennifer C Carr; Donghong Wang; M Sue O'Dorisio; Thomas M O'Dorisio; James R Howe
Journal:  J Surg Res       Date:  2014-01-29       Impact factor: 2.192

2.  Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.

Authors:  Timothy Weatherall; Jason Denbo; John Sharpe; Michael Martin; Thomas O'Brien; Rajib Gupta; Kenneth Groshart; Stephen Behrman; Paxton Dickson
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

3.  Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience.

Authors:  Megha S Uppin; Shantveer G Uppin; Chittiboyina Shiva Prasada Venkata Sunil; Monalisa Hui; Tara Roshni Paul; Nagari Bheerappa
Journal:  J Gastrointest Oncol       Date:  2017-02

4.  Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: a case report and literature review.

Authors:  Shingo Yoshimachi; Hideo Ohtsuka; Takeshi Aoki; Takayuki Miura; Kyohei Ariake; Kunihiro Masuda; Masaharu Ishida; Masamichi Mizuma; Hiroki Hayashi; Kei Nakagawa; Takanori Morikawa; Fuyuhiko Motoi; Atsushi Kanno; Atsushi Masamune; Fumiyoshi Fujishima; Hironobu Sasano; Takashi Kamei; Takeshi Naitoh; Michiaki Unno
Journal:  Clin J Gastroenterol       Date:  2019-07-24

Review 5.  Management of gastric and duodenal neuroendocrine tumors.

Authors:  Yuichi Sato; Satoru Hashimoto; Ken-Ichi Mizuno; Manabu Takeuchi; Shuji Terai
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

6.  Major and Minor Duodenal Papilla Neuroendocrine Tumors in Type 1 Neurofibromatosis: Case Report.

Authors:  M R Zandomeni; M Chahdi Beltrame; M de Santibañes; O Mazza; J Pekolj; E de Santibañes; R Sanchez Claria
Journal:  J Gastrointest Cancer       Date:  2018-03

7.  Ampullary neuroendocrine neoplasms: surgical experience of a rare and challenging entity.

Authors:  A C Milanetto; C Pasquali; M Da Broi; T Brambilla; G Capretti; A Zerbi
Journal:  Langenbecks Arch Surg       Date:  2018-07-24       Impact factor: 3.445

8.  A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.

Authors:  Georgios Antonios Margonis; Mario Samaha; Yuhree Kim; Lauren McLendon Postlewait; Pamela Kunz; Shishir Maithel; Thuy Tran; Nickolas Berger; T Clark Gamblin; Matthew G Mullen; Todd W Bauer; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2016-03-23       Impact factor: 3.452

9.  Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.

Authors:  Bobby V M Dasari; Sarah Al-Shakhshir; Timothy M Pawlik; Tahir Shah; Ravi Marudanayagam; Robert P Sutcliffe; Darius F Mirza; Paolo Muiesan; Keith J Roberts; John Isaac
Journal:  J Gastrointest Surg       Date:  2018-06-04       Impact factor: 3.452

10.  Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?

Authors:  Adriana C Gamboa; Yuan Liu; Rachel M Lee; Mohammad Y Zaidi; Charles A Staley; David A Kooby; Joshua H Winer; Mihir M Shah; Maria C Russell; Kenneth Cardona; Shishir K Maithel
Journal:  J Surg Oncol       Date:  2019-10-16       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.